Arkaitz Imaz

1.8k citations

81 papers · 744 indexed · h-index 16

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 38
- HIV Research and Treatment 38
Infectious Diseases 69
- HIV/AIDS drug development and treatment 54
- HIV/AIDS Research and Interventions 38

Co-authors: Daniel Podzamczer (33 shared papers)Esteban Ribera (16 shared papers)Vicenç Falcó (14 shared papers)Adrián Curran (18 shared papers)Juan Tiraboschi (18 shared papers)Jordí Niubó (18 shared papers)Josep M. Llibre (18 shared papers)Peré Domingo (22 shared papers)
Journals: Journal of Antimicrobial Chemotherapy (10 papers)HIV Medicine (10 papers)Clinical Infectious Diseases (6 papers)Antiviral Therapy (6 papers)Journal of the International AIDS Society (5 papers)
Partner nations: Spain United States United Kingdom

In The Last Decade

Arkaitz Imaz

74 papers receiving 726 citations

Peers

Countries citing papers authored by Arkaitz Imaz

Since Specialization

Citations

This map shows the geographic impact of Arkaitz Imaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arkaitz Imaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arkaitz Imaz more than expected).

Fields of papers citing papers by Arkaitz Imaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arkaitz Imaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arkaitz Imaz. The network helps show where Arkaitz Imaz may publish in the future.

Co-authors

The 25 scholars most cited alongside Arkaitz Imaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arkaitz Imaz Line = papers co-authored together Arkaitz Imaz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment JAIDS Journal of Acquired Immune Deficiency Syndromes ·Enrique Bernal, José María Pérez Gómez, Inmaculada Jarrín, Alfredo Cano, Ángeles Muñoz, Antonia Alcaraz, Arkaitz Imaz, José Antonio Iribarren, María Rivero, Piedad Arazo, Félix Gutiérrez, (unknown)	2018	51
2	Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Arkaitz Imaz, S Villar del Saz, Ma Angels Ribas, Adrián Curran, Estrella Caballero, Vicenç Falcó, Manel Crespo, I Ocaña, M. Medina Díaz, Enrique Ruíz de Gopegui, Melcior Riera, Esteban Ribera	2009	41
3	Bacterial pneumonia in HIV‐infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome HIV Medicine ·Adrián Curran, Vicenç Falcó, Manuel Crespo, Xavier Martínez, Esteban Ribera, S Villar del Saz, Arkaitz Imaz, Ermengol Coma, Álex Ferrer, Albert Pahissa	2008	39
4	Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services HIV Medicine ·Gary Whitlock, Konstantinos Protopapas, José Ignacio Bernardino, Arkaitz Imaz, Adrián Curran, Christof Stingone, Sivapatham Shivasankar, Sarah Edwards, Sophie Herbert, Κonstantinos Thomas, Rafael Micán, Paula Prieto, Jorge García, Massimo Andreoni, Samantha V. Hill, Hajra Okhai, David Stuart, Adam Bourne, Katie Conway	2021	39
5	High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial PLoS ONE ·Juan Pasquau, Carmen Hidalgo-Tenorio, Marisa Montes, Alberto Romero-Palacios, Jorge Vergas, Isabel Sanjoaquín, José Hernández‐Quero, Koldo Aguirrebengoa, Francisco Orihuela, Arkaitz Imaz, Maria José Ríos-Villegas, Juan Flores, María Carmen Fariñas, Pilar Vázquez, Marı́a José Galindo, Isabel García-Mercé, Fernando Lozano, Ignacio de los Santos, Samantha E de Jesus, Coral García-Vallecillos, (unknown)	2018	30
6	HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen The Journal of Infectious Diseases ·Arkaitz Imaz, Javier Martínez‐Picado, Jordí Niubó, Angela D. M. Kashuba, Elena Ferrer, Dan Ouchi, Craig Sykes, Nerea Rozas, Laura Acerete, Jordi Curto, Antonia Vila, Daniel Podzamczer	2016	24
7	Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients Journal of Antimicrobial Chemotherapy ·Adrián Curran, M. Gutirerrez, Elisabet Deig, Gràcia Mateo, R. M. Lopez, Arkaitz Imaz, M. Crespo, I Ocaña, Peré Domingo, Esteban Ribera	2010	22
8	Short Communication: Focal Encephalitis Related to Viral Escape and Resistance Emergence in Cerebrospinal Fluid in a Patient on Lopinavir/Ritonavir Monotherapy with Plasma HIV-1 RNA Suppression AIDS Research and Human Retroviruses ·Arkaitz Imaz, Núria Cayuela, Jordí Niubó, Juan Tiraboschi, Cristina Izquierdo, Carmen Cabellos, Daniel Podzamczer	2014	21
9	Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice. PubMed ·Arkaitz Imaz, Vicenç Falcó, Esteban Ribera	2011	21
10	Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals Journal of Antimicrobial Chemotherapy ·Arkaitz Imaz, Josep M. Llibre, Marta Mora-Rillo, Gràcia Mateo, Ángela Camacho, José Ramón Blanco, Adrián Curran, José Ramón Santos, E. Caballero, Isabel Bravo, Francisco Gayá, Peré Domingo, Antonio Rivero, Vicenç Falcó, B. Clotet, Esteban Ribera	2010	19
11	Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV Expert Review of Anti-infective Therapy ·Arkaitz Imaz, Daniel Podzamczer	2017	19
12	Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant Infection and Drug Resistance ·Celia Perales, Qian Chen, María Eugenia Soria, Josep Gregori, Damir García‐Cehic, Leonardo Nieto-Aponte, Lluı́s Castells, Arkaitz Imaz, Meritxell Llorens-Revull, Esteban Domingo, Marı́a Buti, Juan Ignacio Esteban, Francisco Rodríguez‐Frias, Josep Quer	2018	18
13	Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain European Journal of Clinical Microbiology & Infectious Diseases ·Yanik Sierra, Aída González-Díaz, Fé Tubau, Arkaitz Imaz, Meritxell Cubero, Jordi Cámara, Josefina Ayats, Sara Martí, Carmen Ardanuy	2019	18
14	Prevalence of methicillin-resistant Staphylococcus aureus colonization in HIV-infected patients in Barcelona, Spain: a cross-sectional study BMC Infectious Diseases ·Arkaitz Imaz, Mariana Camoez, Silvana Di Yacovo, Oriol Gasch, M.Á. Domínguez, Antonia Vila, Margarita Maso-Serra, Miquel Pujol, Daniel Podzamczer	2015	18
15	Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients. PubMed ·Arkaitz Imaz, Miquel Pujol, Patricia Barragán, M.Á. Domínguez, Juan Tiraboschi, Daniel Podzamczer	2010	17
16	Short-Term and Long-Term Clinical and Immunological Consequences of Stopping Antiretroviral Therapy in HIV-Infected Patients with Preserved Immune Function Antiviral Therapy ·Arkaitz Imaz, Montserrat Olmo, María Luz Pintos Peñaranda, Félix Gutiérrez, Joan Romeu, María Larrousse, Peré Domingo, José A. Oteo, Jordi Curto, Concepción Vilallonga, Mar Masiá, José López‐Aldeguer, José Antonio Iribarren, Daniel Podzamczer, (unknown)	2012	16
17	Response‐Guided Therapy for Chronic Hepatitis C Virus Infection in Patients Coinfected with HIV: A Pilot Trial Clinical Infectious Diseases ·Eva Van den Eynde, Manuel Crespo, Juan Ignacio Esteban, R Jardí, Esteban Ribera, Judit Carbonell, Francisco Rodríguez‐Frias, Vicenç Falcó, Adrián Curran, Arkaitz Imaz, S Villar del Saz, I Ocaña, Rafael Esteban, Albert Pahissa	2009	15
18	Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group Journal of Antimicrobial Chemotherapy ·(unknown), Polyana Monteiro, Peré Domingo, J. Villar, Arkaitz Imaz, Estebán Martínez, I. Fernandez, Hernando Knobel, Daniel Podzamczer, J. A. Iribarren, María Luz Pintos Peñaranda, Manuel Crespo, (unknown), (unknown), Esteban Ribera, Jordi Navarro, (unknown), Polyana Monteiro, (unknown), J. Villar, (unknown), Maialen Ibarguren, (unknown), Melchor Riera	2014	15
19	Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen Journal of Antimicrobial Chemotherapy ·Joaquín Burgos, Manuel Crespo, Vicenç Falcó, Adrián Curran, Arkaitz Imaz, Peré Domingo, Daniel Podzamczer, M. G. Mateo, Eva Van den Eynde, Silvia G. del Villar, Esteban Ribera	2012	14
20	Impact of prior pneumococcal vaccination on clinical outcomes in HIV‐infected adult patients hospitalized with invasive pneumococcal disease HIV Medicine ·Arkaitz Imaz, Vicenç Falcó, María Luz Pintos Peñaranda, Queralt Jordano, Xavier Martínez, C. Figueras Nadal, Adrián Curran, AM Planes, David Dalmau, Esteban Ribera, Melchor Riera, E. Ruiz de Gopegui, Albert Pahissa	2009	14

About Arkaitz Imaz

Arkaitz Imaz is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Epidemiology, having authored 81 papers that have together received 744 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (54 papers), HIV Research and Treatment (38 papers), HIV/AIDS Research and Interventions (38 papers), HIV-related health complications and treatments (21 papers), Hepatitis C virus research (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Virology (390 citations), Infectious Diseases (574 citations), Emergency Medicine (111 citations), Hepatology (54 citations) and Epidemiology (221 citations). Arkaitz Imaz has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Daniel Podzamczer, Esteban Ribera, Vicenç Falcó, Adrián Curran, Juan Tiraboschi, Jordí Niubó, Josep M. Llibre, Peré Domingo, S Villar del Saz and Manuel Crespo. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, HIV Medicine, Clinical Infectious Diseases, Antiviral Therapy and Journal of the International AIDS Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact